AI Model Improves Cell Culture Forecasting with Raman Data Fusion.

Johnny Peng, Thanh Tung Khuat, Ellen Otte, Katarzyna Musial, Bogdan Gabrys· June 26, 2026 View original

Summary

Researchers developed an adaptive AI framework, GB-Latent ODE with MP-JIT-FT, to forecast critical parameters in biopharmaceutical cell culture processes. This method integrates Raman spectroscopy data to enhance prediction accuracy and provide multiple plausible future paths for process adjustment.

Biopharmaceutical manufacturing relies heavily on mammalian cell cultures, but maintaining optimal conditions is challenging due to parameter drift and sparse, irregular measurements. Traditional forecasting often fails to provide timely insights, leading to potential production issues. This new research introduces an adaptive framework designed to overcome these limitations. The framework combines a Gated Bottleneck Latent Ordinary Differential Equation (GB-Latent ODE) with Multi-Path Just-In-Time Fine Tuning (MP-JIT-FT). The GB-Latent ODE efficiently processes high-dimensional, sparse inputs, while MP-JIT-FT retrieves similar historical data to generate multiple plausible future scenarios, each with a confidence score, rather than a single average forecast. A key innovation is the fusion of Raman spectroscopy data, which acts as a machine-learning soft sensor to enrich sparse offline measurements. This data enrichment significantly improves training robustness. Experiments on bioreactor runs demonstrated that this combined approach outperforms baseline models, especially when early process behaviors diverge into different outcomes.

Why it matters

This research offers a significant advancement for biopharmaceutical professionals by enabling earlier and more accurate forecasting of cell culture processes, potentially preventing costly deviations and improving product quality and yield.

How to implement this in your domain

  1. 1Evaluate current cell culture monitoring systems for data sparsity and irregularity.
  2. 2Investigate integrating Raman spectroscopy or similar real-time analytical technologies into bioprocesses.
  3. 3Explore implementing advanced machine learning models like Latent ODEs for predictive analytics.
  4. 4Develop a strategy for multi-path forecasting to assess various potential outcomes and risks.
  5. 5Train staff on interpreting complex AI-driven forecasts and making timely process adjustments.

Who benefits

BiopharmaceuticalsBiotechnologyPharmaceuticalsLife Sciences

Key takeaways

  • An adaptive AI framework significantly improves cell culture process forecasting.
  • Raman spectroscopy data fusion enhances model robustness and prediction accuracy.
  • Multi-path forecasting provides more nuanced insights than single-averaged predictions.
  • Early intervention based on these forecasts can prevent costly bioprocess deviations.

Original post by Johnny Peng, Thanh Tung Khuat, Ellen Otte, Katarzyna Musial, Bogdan Gabrys

"arXiv:2606.26520v1 Announce Type: new Abstract: Mammalian cell-culture processes underpin the manufacture of many biopharmaceuticals, yet keeping a run on track is hard: critical process parameters drift over days, and an off-specification trend is often confirmed too late to int…"

View on X

Originally posted by Johnny Peng, Thanh Tung Khuat, Ellen Otte, Katarzyna Musial, Bogdan Gabrys on X · view source

Want to go deeper?

Turn these trends into skills with Learnijoy's hands-on AI & tech courses.

Explore courses